285 related articles for article (PubMed ID: 33177501)
1. The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition.
Tristán-Ramos P; Rubio-Roldan A; Peris G; Sánchez L; Amador-Cubero S; Viollet S; Cristofari G; Heras SR
Nat Commun; 2020 Nov; 11(1):5712. PubMed ID: 33177501
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA miR-128 represses LINE-1 (L1) retrotransposition by down-regulating the nuclear import factor TNPO1.
Idica A; Sevrioukov EA; Zisoulis DG; Hamdorf M; Daugaard I; Kadandale P; Pedersen IM
J Biol Chem; 2017 Dec; 292(50):20494-20508. PubMed ID: 28974576
[TBL] [Abstract][Full Text] [Related]
3. miR-128 Restriction of LINE-1 (L1) Retrotransposition Is Dependent on Targeting hnRNPA1 mRNA.
Fung L; Guzman H; Sevrioukov E; Idica A; Park E; Bochnakian A; Daugaard I; Jury D; Mortazavi A; Zisoulis DG; Pedersen IM
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010097
[TBL] [Abstract][Full Text] [Related]
4. LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY.
Zhang R; Zhang F; Sun Z; Liu P; Zhang X; Ye Y; Cai B; Walsh MJ; Ren X; Hao X; Zhang W; Yu J
Cancer Res; 2019 Sep; 79(17):4453-4465. PubMed ID: 31289132
[TBL] [Abstract][Full Text] [Related]
5. Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers.
Jung H; Choi JK; Lee EA
Genome Res; 2018 Aug; 28(8):1136-1146. PubMed ID: 29970450
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer.
Chen L; Dahlstrom JE; Chandra A; Board P; Rangasamy D
Breast Cancer Res Treat; 2012 Nov; 136(1):129-42. PubMed ID: 23053642
[TBL] [Abstract][Full Text] [Related]
7. Line-1: Implications in the etiology of cancer, clinical applications, and pharmacologic targets.
Khalid M; Bojang P; Hassanin AAI; Bowers EC; Reyes-Reyes EM; Ramos IN; Ramos KS
Mutat Res Rev Mutat Res; 2018; 778():51-60. PubMed ID: 30454683
[TBL] [Abstract][Full Text] [Related]
8. A potential role for the nucleolus in L1 retrotransposition.
Goodier JL; Ostertag EM; Engleka KA; Seleme MC; Kazazian HH
Hum Mol Genet; 2004 May; 13(10):1041-8. PubMed ID: 15028673
[TBL] [Abstract][Full Text] [Related]
9. Large Deletions, Cleavage of the Telomeric Repeat Sequence, and Reverse Transcriptase-Mediated DNA Damage Response Associated with Long Interspersed Element-1 ORF2p Enzymatic Activities.
Kines KJ; Sokolowski M; DeFreece C; Shareef A; deHaro DL; Belancio VP
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397133
[TBL] [Abstract][Full Text] [Related]
10. Functional microRNAs and target sites are created by lineage-specific transposition.
Spengler RM; Oakley CK; Davidson BL
Hum Mol Genet; 2014 Apr; 23(7):1783-93. PubMed ID: 24234653
[TBL] [Abstract][Full Text] [Related]
11. Engineered LINE-1 retrotransposition in nondividing human neurons.
Macia A; Widmann TJ; Heras SR; Ayllon V; Sanchez L; Benkaddour-Boumzaouad M; Muñoz-Lopez M; Rubio A; Amador-Cubero S; Blanco-Jimenez E; Garcia-Castro J; Menendez P; Ng P; Muotri AR; Goodier JL; Garcia-Perez JL
Genome Res; 2017 Mar; 27(3):335-348. PubMed ID: 27965292
[TBL] [Abstract][Full Text] [Related]
12. hnRNPL and nucleolin bind LINE-1 RNA and function as host factors to modulate retrotransposition.
Peddigari S; Li PW; Rabe JL; Martin SL
Nucleic Acids Res; 2013 Jan; 41(1):575-85. PubMed ID: 23161687
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3.
Zhao B; Han H; Chen J; Zhang Z; Li S; Fang F; Zheng Q; Ma Y; Zhang J; Wu N; Yang Y
Cancer Lett; 2014 Jan; 342(1):43-51. PubMed ID: 23981581
[TBL] [Abstract][Full Text] [Related]
14. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer.
Long XB; Sun GB; Hu S; Liang GT; Wang N; Zhang XH; Cao PP; Zhen HT; Cui YH; Liu Z
Oncol Rep; 2009 Nov; 22(5):1189-95. PubMed ID: 19787239
[TBL] [Abstract][Full Text] [Related]
15. RNA ligation precedes the retrotransposition of U6/LINE-1 chimeric RNA.
Moldovan JB; Wang Y; Shuman S; Mills RE; Moran JV
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20612-20622. PubMed ID: 31548405
[TBL] [Abstract][Full Text] [Related]
16. Characterization of LINE-1 ribonucleoprotein particles.
Doucet AJ; Hulme AE; Sahinovic E; Kulpa DA; Moldovan JB; Kopera HC; Athanikar JN; Hasnaoui M; Bucheton A; Moran JV; Gilbert N
PLoS Genet; 2010 Oct; 6(10):. PubMed ID: 20949108
[TBL] [Abstract][Full Text] [Related]
17. Whole-genome sequencing reveals principles of brain retrotransposition in neurodevelopmental disorders.
Jacob-Hirsch J; Eyal E; Knisbacher BA; Roth J; Cesarkas K; Dor C; Farage-Barhom S; Kunik V; Simon AJ; Gal M; Yalon M; Moshitch-Moshkovitz S; Tearle R; Constantini S; Levanon EY; Amariglio N; Rechavi G
Cell Res; 2018 Feb; 28(2):187-203. PubMed ID: 29327725
[TBL] [Abstract][Full Text] [Related]
18. Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase.
Garcia-Perez JL; Doucet AJ; Bucheton A; Moran JV; Gilbert N
Genome Res; 2007 May; 17(5):602-11. PubMed ID: 17416749
[TBL] [Abstract][Full Text] [Related]
19. Spliced integrated retrotransposed element (SpIRE) formation in the human genome.
Larson PA; Moldovan JB; Jasti N; Kidd JM; Beck CR; Moran JV
PLoS Biol; 2018 Mar; 16(3):e2003067. PubMed ID: 29505568
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.
Lee YS; Dutta A
Genes Dev; 2007 May; 21(9):1025-30. PubMed ID: 17437991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
